Vitamin D and calcium are essential for normal skeletal growth and for maintaining the mechanical and structural integrity of the skeleton. Reduced intake of calcium and vitamin D may be associated with reduced bone mass and osteoporosis while a chronic and severe vitamin D deficiency may lead to osteomalacia. Given the importance of vitamin D in bone homeostasis, common polymorphisms in the vitamin D receptor gene were the first to be investigated as possible determinants of bone mass and fracture risk. Even though results are still conflicting and the molecular mechanisms by which these polymorphisms influence receptor activity remain in part to be investigated, and additional important issue is represented by their potential pharmacogenomic and pharmacogenetic implications. This review analyzes major pharmacogenetic studies of polymorphisms in the vitamin D receptor gene and osteoporosis. © 2009 Future Medicine Ltd.

Gennari, L., Merlotti, D., De Paola, V., Martini, G., Nuti, R. (2009). Update on the pharmacogenetics of the vitamin D receptor and osteoporosis. PHARMACOGENOMICS, 10(3), 417-433 [10.2217/14622416.10.3.417].

Update on the pharmacogenetics of the vitamin D receptor and osteoporosis

Gennari L.;Merlotti D.;Martini G.;Nuti R.
2009-01-01

Abstract

Vitamin D and calcium are essential for normal skeletal growth and for maintaining the mechanical and structural integrity of the skeleton. Reduced intake of calcium and vitamin D may be associated with reduced bone mass and osteoporosis while a chronic and severe vitamin D deficiency may lead to osteomalacia. Given the importance of vitamin D in bone homeostasis, common polymorphisms in the vitamin D receptor gene were the first to be investigated as possible determinants of bone mass and fracture risk. Even though results are still conflicting and the molecular mechanisms by which these polymorphisms influence receptor activity remain in part to be investigated, and additional important issue is represented by their potential pharmacogenomic and pharmacogenetic implications. This review analyzes major pharmacogenetic studies of polymorphisms in the vitamin D receptor gene and osteoporosis. © 2009 Future Medicine Ltd.
2009
Gennari, L., Merlotti, D., De Paola, V., Martini, G., Nuti, R. (2009). Update on the pharmacogenetics of the vitamin D receptor and osteoporosis. PHARMACOGENOMICS, 10(3), 417-433 [10.2217/14622416.10.3.417].
File in questo prodotto:
File Dimensione Formato  
Gennari L (Pharmacogenomics Mar 2009).pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 827.39 kB
Formato Adobe PDF
827.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/22887
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo